
CSL Limited
CMXHF | OTC
$128.50
+$6.50 (+5.33%)
At close: Sep 22, 2026, 4:00 PM ET
$128.50
$0 (0.00%)
After-hours:
Sep 23, 2026, 4:00 PM ET
TTM Period Ending | Q4 2026 Jun 29, 2026 | Q2 2026 Dec 30, 2025 | Q4 2025 Jun 29, 2025 | Q2 2025 Dec 30, 2024 | Q4 2024 Jun 29, 2024 | Q2 2024 Dec 30, 2023 | Q4 2023 Jun 29, 2023 | Q2 2023 Dec 30, 2022 | Q4 2022 Jun 29, 2022 | Q2 2022 Dec 30, 2021 | Q4 2021 Jun 29, 2021 | Q2 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.74B | 15.7B | 15.47B | 14.98B | 15.13B | 14.28B | 9.56B | 7.93B | 7.31B | 7.6B | 7.45B | 7.33B |
Cost of Revenue | 8.22B | 8.06B | 7.83B | 7.62B | 7.76B | 7.36B | 6.82B | 5.72B | 4.8B | 4.8B | 4.64B | 4.45B |
Gross Profit | 7.52B | 7.63B | 7.64B | 7.36B | 7.37B | 6.92B | 6.4B | 5.87B | 5.44B | 5.57B | 5.85B | 6.08B |
Operating Income | 4.03B | 4.04B | 3.37B | 2.57B | 3.28B | 3.5B | 2.96B | 2.79B | 1.75B | 1.83B | 1.9B | 2.31B |
Interest Income | 30.16M | 39.06M | 37.59M | 36.1M | 40.12M | 24.11M | 38.65M | 51.19M | 16.68M | 3.03M | 3.95M | 4.97M |
Pretax Income | -4.02B | 1.61B | 3.77B | 3.04B | 2.98B | 3.17B | 1.68B | 1.6B | 1.68B | 1.77B | 1.82B | 2.19B |
Net Income | -2.53B | 1.44B | 3.04B | 2.38B | 2.35B | 2.55B | 2.24B | 2.15B | 2.88B | 2.96B | 2.47B | 2.82B |
Selling & General & Admin | 2.12B | 2.46B | 2.62B | 1.84B | 1.18B | 1.69B | 1.74B | 1.47B | 1.27B | 1.4B | 1.37B | 1.18B |
Research & Development | 1.23B | 1.35B | 1.39B | 1.42B | 1.1B | 980.82M | 1.24B | 1.23B | 1.12B | 1.04B | 1.01B | 956.08M |
Other Expenses | 145.89M | -215.95M | 260.05M | 980.8M | 504.8M | 525.49M | 985.86M | 377.26M | 236.74M | 245.8M | 258.88M | 332.93M |
Operating Expenses | 3.49B | 3.6B | 4.26B | 4.24B | 2.79B | 2.67B | 3.43B | 3.07B | 2.63B | 2.69B | 2.64B | 2.46B |
Interest Expense | 430.81M | 432.52M | 436.58M | 445.88M | 489.86M | 617.71M | 562.58M | 299.75M | 160.47M | 130.98M | 175.77M | 195.65M |
Selling & Marketing Expenses | n/a | 862M | 1.62B | 1.17B | 774.35M | 1.15B | 1.14B | 873.31M | 743.36M | 782.25M | 773.73M | 435.19M |
Cost & Expenses | 11.72B | 11.66B | 12.09B | 11.86B | 11.3B | 10.78B | 7.66B | 6.2B | 5.55B | 5.71B | 5.5B | 5.02B |
Income Tax Expense | -1.08B | 203.53M | 591.8M | 688.64M | 433.11M | 322.74M | 423.93M | 464.34M | 515.26M | 523.83M | 611.06M | 633.4M |
Shares Outstanding (Basic) | 478.91M | 483.58M | 484.21M | 483.88M | 483.25M | 482.83M | 484.59M | 482.04M | 481.71M | 456.75M | 455.11M | 454.79M |
Shares Outstanding (Diluted) | 478.91M | 486.11M | 486.49M | 485.96M | 485.75M | 484.98M | 484.59M | 483.63M | 518.49M | 458.11M | 456.23M | 456.2M |
EPS (Basic) | -5.29 | 2.98 | 6.28 | 6.48 | 5.47 | 4.37 | 2.93 | 2.68 | 2.91 | 3.14 | 3.20 | 2.92 |
EPS (Diluted) | -5.30 | 2.96 | 6.25 | 4.89 | 2.71 | 3.12 | 2.87 | 2.61 | 4.72 | 5.05 | 5.45 | 6.19 |
EBITDA | 5.07B | 5.15B | 5.23B | 5.6B | 4.73B | 3.89B | 2.29B | 1.57B | 3.23B | 3.29B | 2.16B | 1.87B |
EBIT | 4.03B | 4.08B | 4.2B | 4.6B | 3.8B | 3.23B | 1.93B | 1.36B | 2.87B | 2.94B | 1.95B | 1.71B |
Depreciation & Amortization | 1.04B | 1.06B | 1.04B | 991.66M | 938M | 663.64M | 434.3M | 285.43M | 354.19M | 354.69M | 208.21M | 152.3M |
Add to Watchlist
Select watchlists to add or remove CMXHF